Correlation Between 23Andme Holding and Organogenesis Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Organogenesis Holdings, you can compare the effects of market volatilities on 23Andme Holding and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Organogenesis Holdings.

Diversification Opportunities for 23Andme Holding and Organogenesis Holdings

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between 23Andme and Organogenesis is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Organogenesis Holdings go up and down completely randomly.

Pair Corralation between 23Andme Holding and Organogenesis Holdings

Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Organogenesis Holdings. In addition to that, 23Andme Holding is 1.25 times more volatile than Organogenesis Holdings. It trades about -0.08 of its total potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.06 per unit of volatility. If you would invest  262.00  in Organogenesis Holdings on August 24, 2024 and sell it today you would earn a total of  140.00  from holding Organogenesis Holdings or generate 53.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

23Andme Holding Co  vs.  Organogenesis Holdings

 Performance 
       Timeline  
23Andme Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Organogenesis Holdings 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Organogenesis Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Organogenesis Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.

23Andme Holding and Organogenesis Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 23Andme Holding and Organogenesis Holdings

The main advantage of trading using opposite 23Andme Holding and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.
The idea behind 23Andme Holding Co and Organogenesis Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Correlations
Find global opportunities by holding instruments from different markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bonds Directory
Find actively traded corporate debentures issued by US companies